Riskpilot← Back to searchSign inGet full accessASKIM LEGESENTER DA
DAActiveOrg 987651733Rådhusgata 23, 1830 AskimGeneral medical practice activities · NACE 8621Est. 20057 employees
Revenue 2024
NOK 5,2M
+17% vs 2022
EBITDA margin
2.6%
+147% vs 2022
Equity ratio
-1.6%
Financial strength
Net profit 2024
NOK 38K
+112% vs 2022
| Revenue | NOK 5,2M | +17% |
| EBITDA | NOK 134K | +147% |
| Net profit | NOK 38K | +112% |
| Total assets | NOK 668K | +127% |
| Equity | NOK -11K | +97% |
| Employees | 7 | — |
Legal name
ASKIM LEGESENTER DA
Org number
987651733
Legal form
Ansvarlig Selskap Med Delt Ansvar
NACE code
8621 · General medical practice activities
Founded
4. januar 2005
Share capital
—
Employees
7 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Deltakerne i fellesskap.
Company purpose
Produksjon av helsetjenester og tjenester og produkter som naturlig hører sammen med dette, samt deltakelse i andre virksomheter innenfor samme bransje.
Address
Rådhusgata 23, 1830 Askim
Phone
+4769819600
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 448 | 4 315 | 4 346 | 4 392 | 5 154 |
| Staff expenses | −2 139 | −2 034 | −2 180 | −2 297 | −2 498 |
| EBITDA | 101 | 199 | 43 | −285 | 134 |
| Depreciation & amort. | −63 | −45 | −46 | −33 | −98 |
| EBIT | 38 | 154 | −3 | −318 | 36 |
| Net financials | −1 | −3 | −2 | −1 | 2 |
| Profit before tax | 37 | 151 | −4 | −318 | 38 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 37 | 151 | −4 | −318 | 38 |
| Item | 2019 | 2020 | 2021 | 2022 | 2024 |
|---|---|---|---|---|---|
| Total assets | 350 | 386 | 497 | 294 | 668 |
| Equity | −140 | 11 | 7 | −312 | −11 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 489 | 375 | 490 | 605 | 679 |
| Total debt | 489 | 375 | 490 | 605 | 679 |
EBITDA margin
2.6%
This company
15.8%
Market median
-84% vs market
20192024
Equity ratio
-1.6%
This company
38.2%
Market median
-104% vs market
20192024
Return on equity
3804800.0%
This company
18.4%
Market median
+20678161% vs market
20192024
Net profit margin
0.7%
This company
8.1%
Market median
-91% vs market
20192024
Asset turnover
7.72×
This company
1.12×
Market median
+589% vs market
20192024
Debt / equity
62.27×
This company
0.62×
Market median
-9944% vs market
20192024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HG Chief Executive Officer | Chief Executive Officer | 2020 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 0% | 0% | 2023 | |
| Company | 0% | 0% | 2020 | |
| Individual | 0% | 0% | 2023 | |
| Individual | 0% | 0% | 2024 | |
| Company | 0% | 0% | 2024 | |
| Individual | 0% | 0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ASKIM LEGESENTER DA also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Halvor Giltvedt | Chief Executive Officer | 0 companies |